PixelBiosciences GmbH was founded in Heidelberg, Germany, and set up headquarters in China, as PixelBiosciences (Suzhou) Co., Ltd. We boasts a proprietary intelligent synthesis platform, nMECA, for innovative drug models. Our focus is on the high-throughput and cost-effective synthesis of RNA and DNA longmers, CRISPR gene editing reagents, and antibody-oligonucleotide conjugates (AOCs). Our products are widely utilized in cutting-edge fields such as gene editing drug research, spatial biology, proteomics, and biomaterials development.

Vision: Committed to providing advanced technologies for novel drug research and development, we aim to become a global leader in innovative drug synthesis tools.